Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNGX
SNGX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNGX News
Soligenix Reports 2025 Financial Results and Upcoming Milestones
4d ago
Newsfilter
Soligenix Reports FY EPS of -$2.14, Beats Estimates
4d ago
seekingalpha
Soligenix Reports 2025 Financial Results and Upcoming Milestones
4d ago
PRnewswire
Soligenix Receives EU Orphan Drug Designation for SGX945
Mar 26 2026
PRnewswire
Soligenix Receives EU Orphan Drug Designation for SGX945
Mar 26 2026
Newsfilter
Soligenix Highlights Positive Results for HyBryte™ in CTCL Treatment
Mar 23 2026
PRnewswire
Soligenix Highlights Positive Results for HyBryte™ in CTCL Treatment
Mar 23 2026
Newsfilter
Soligenix Publishes Summary of HyBryte™ Clinical Trials
Mar 19 2026
PRnewswire
Soligenix Publishes Summary of HyBryte™ Clinical Trials for CTCL
Mar 19 2026
Newsfilter
Soligenix Receives PIM Designation for SGX945 in the UK
Mar 10 2026
PRnewswire
Soligenix Receives UK PIM Designation for SGX945
Mar 10 2026
Newsfilter
Soligenix Receives Positive EMA Orphan Drug Recommendation
Feb 26 2026
PRnewswire
Soligenix Receives Positive EMA Orphan Drug Recommendation
Feb 26 2026
Newsfilter
Soligenix to Present at BIO Investment Summit
Feb 24 2026
PRnewswire
Soligenix to Present at BIO Investment Summit
Feb 24 2026
Newsfilter
Soligenix Outlines Strategic Vision for 2026
Feb 12 2026
PRnewswire
Show More News
